Results

Total Results: 1,494 records

Showing results for "harms".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Objectives This report summarizes the evidence on the comparative efficacy, effectiveness, and harms … KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, or adverse … KQ4: What are the comparative benefits and harms of drug therapies for RA in subgroups of patients based … Our major findings are presented in this section by type of drug comparison for benefits and harms ( … Summary of findings with strength of evidence Key Comparisons Efficacy Strength of Evidence Harms
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
    January 01, 2009 - Public payer Nomination Summary: The nominator questions the comparative effectiveness and harms … The nominator also questions whether there are differences in the effectiveness or harms of these treatments … For patients, what are the potential harms of TBI treatment interventions? 3.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
    June 01, 2018 - Geriatrics Society (AGS) is seeking a new updated systematic review to focus on evaluating both the harms … The Key Questions Question 1: What are the benefits and harms for antipsychotics compared to each other … What are the benefits and harms for antipsychotics compared to each other, placebo, or non-drug approaches … What are the benefits and harms for antipsychotics compared to each other, placebo, or non-drug approaches … What are the benefits and harms for antipsychotics compared to each other, placebo, or non-drug approaches
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - harms, infections, cardiovascular events, cognitive harms, and psychological harms (e.g., depression … gastrointestinal-related harms, cardiovascular-related harms, kidney- related harms, falls, fractures … , motor vehicle accidents, endocrinological A-3 harms, infections, cognitive harms, and psychological … harms (e.g., depression)? … Misuse, opioid use disorder, overdose and other harms KQ2.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
    December 11, 2018 - What are the benefits and harms of noninvasive nonpharmacologic therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic therapies compared with exercise? … What are the benefits and harms of noninvasive nonpharmacologic therapies compared with biofeedback?
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
    July 27, 2023 - What are the frequency and severity of harms associated with anticoagulant use in the inpatient and … For this topic that focuses on a PSP that may address a variety of different harms, we will answer … Review Questions 1 and 2 by focusing on the harms and patient safety measures or indicators that are … Intervention RQs 1-4: Not applicable (description of harms associated with anticoagulant use in the … Harms Due to Anticoagulants.
  7. effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
    January 01, 2016 - , p<0.05 NR NA 164 28 NA 20 71 NA Bendinelli, 2018 4 ETI RSI 175 ETI No RSI (no medication ETI) 85 Harms … 0.53 NR NA 27 148 15.4% 10 75 11.7% Bendinelli, 2018 4 ETI RSI 192 ETI No RSI (no medication ETI) 91 Harms … , p=0.59 NR NA 28 164 NA 16 75 NA Bendinelli, 2018 4 ETI RSI 171 ETI No RSI (no medication ETI) 89 Harms … 0.83 NR NA 20 151 11.7% 8 81 9.0% Bendinelli, 2018 4 ETI RSI 187 ETI No RSI (no medication ETI) 85 Harms … ETI RSI using fentayl, midazolam, and succinylcholine; preceded by ≥3 minutes of preoxygenation 157 Harms
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
    February 01, 2013 - KQ 2: What are the harms of RLS treatments? … For KQ 2 (What are the harms of RLS treatments?) … What are the harms from RLS treatments? a. … What are the long-term harms from treatment? KQ 3. … KQ 2: What are the harms of RLS treatments?
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - Factors influencing benefits and harms often depend on distinct physiologic processes. … Describe whether or not these outcomes reflect the most important benefits or harms. … Describe whether these outcomes reflect the most important benefits or harms. … No harms were being evaluated. … No harms were being evaluated.
  10. effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
    January 01, 2009 - Factors influencing benefits and harms often depend on distinct physiologic processes. … Describe whether or not these outcomes reflect the most important benefits or harms. … Describe whether these outcomes reflect the most important benefits or harms. … No harms were being evaluated. … No harms were being evaluated.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_executive.pdf
    November 01, 2012 - KQ 1c: Harms in HCBS and NHs Two studies provided low-strength evidence that harms differed between … of other harms. … KQ 1c Harms • Two studies provided low-strength evidence (high risk of bias) that harms differed. … other harms … and social harms 11 Table B.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-1.pdf
    July 01, 2019 - Systematic Reviews Methods Guide www.ahrq.gov Presenter Presentation Notes Prioritization and Selection of Harms … for Inclusion in Systematic Reviews This presentation entitled: Prioritization and Selection of Harms … Prioritization and Selection of Harms for Inclusion in Systematic Reviews. … Focuses on Comparative Effectiveness Reviews (CERs): − Systematic reviews comparing effectiveness and harms … heterogeneity may also explain widely varying results. ► If an intervention truly benefits some patients and harms
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rural-telehealth-disposition-comments.pdf
    December 26, 2022 - • Harms. … Peer reviewers requested additional information on whether the studies have addressed potential harms … We have added text about the lack of harms to the limitations of the literature and the implications … Reported outcomes, including harms, varied widely across studies. … Many studies did not explicitly define, and then measure potential harms or unintended negative
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prehospital-airway-management-protocol.pdf
    December 20, 2019 - Specifically, this review will focus on comparing the benefit and harms across three different airway … What are the comparative benefits and harms of bag valve mask versus supraglottic airway for patients … Are the comparative benefits and harms modified by: i. Techniques or devices used? ii. … Are the comparative benefits and harms modified by: i. Techniques or devices used? ii. … Are the comparative benefits and harms modified by: i. Techniques or devices used? ii.
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
    January 01, 2006 - How do these benefits and harms change with dosage and duration of treatment, and what is the evidence … Do the comparative benefits and harms of oral treatments for osteoarthritis vary for certain demographic … Harms: hypertension, congestive heart failure (CHF), edema, and impaired renal function • All NSAIDs … Harms: hepatotoxicity • Clinically significant hepatotoxicity was rare. … Balance of evidence and harms Each of the analgesics evaluated in this report was associated with a
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - benefits and harms of treatments for RLS. … Question 2 What are the harms from RLS treatments? a. … What are the harms from RLS treatments when compared to placebo or no treatment? b. … What are the harms from RLS treatments when compared to other active treatments? c. … What are the long-term harms from treatment?
  17. effectivehealthcare.ahrq.gov/sites/default/files/protocol-social-isolation.pdf
    January 01, 2013 - Among older adults, what are the harms associated with interventions (e.g., volunteerism, peer support … limited to Emergency Department visits, hospitalizations, primary and specialty care appointments) • Harms … social isolation and loneliness Adults 60+ years old Health outcomes Health care utilization Harms … arrow labeled "Question 2" connects "Interventions that target social isolation and loneliness" to harms
  18. effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
    November 03, 2020 - A few studies evaluated outcomes pertaining to opioid-related harms (such as overdose or opioid use … They balance the need/indication for opioids with the potential harms well. … This is also true for factors associated with harms. … All interventions where harms outweigh benefits should be minimized. … If the question is “what harms are associated with opioid prescribing?”
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ankyloglossia_research-protocol.pdf
    June 30, 2014 - Key Question 1 (KQ1) What are the benefits and harms of various treatments in breastfeeding newborns … Key Question 2a + b (KQ2) KQ 2a What are the benefits and harms of various treatments* in newborns, … Harms may occur at any point after the intervention is received. … Harms may occur at any point after the intervention is received. Figure 2. … (McHarm) for harms outcomes Two senior investigators will independently assess each included study
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
    December 05, 2018 - to women of not being treated with pharmacotherapy11, 23-25 or harms to infants of not being breastfed … Key Questions (KQs) 3 and 4 focus on maternal and fetal harms and comparative harms of pharmacologic … A Contextual Question (CQ) asks about the harms of not treating a disorder or stopping or switching … • Maternal harms All other outcomes 7 PICOTS Inclusion Exclusion o Harms specific … For harms, we may elect to summarize studies by both medication and disorder, depending on the volume

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: